BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243,215 | -15.7% | 4,843 | +6.1% | 0.02% | -16.0% |
| Q2 2023 | $288,571 | +31.9% | 4,566 | -6.1% | 0.02% | +25.0% |
| Q1 2023 | $218,741 | -1.5% | 4,862 | +44.1% | 0.02% | -16.7% |
| Q3 2022 | $222,000 | +0.9% | 3,375 | -2.1% | 0.02% | +26.3% |
| Q1 2022 | $220,000 | -51.0% | 3,446 | -17.7% | 0.02% | -34.5% |
| Q4 2021 | $449,000 | -19.7% | 4,189 | -23.1% | 0.03% | -25.6% |
| Q3 2021 | $559,000 | -6.8% | 5,446 | -20.2% | 0.04% | -2.5% |
| Q2 2021 | $600,000 | +54.6% | 6,826 | +70.9% | 0.04% | +42.9% |
| Q1 2021 | $388,000 | -6.5% | 3,995 | +7.9% | 0.03% | -12.5% |
| Q4 2020 | $415,000 | +27.3% | 3,703 | +5.2% | 0.03% | +14.3% |
| Q3 2020 | $326,000 | -23.3% | 3,521 | -35.4% | 0.03% | -31.7% |
| Q2 2020 | $425,000 | – | 5,453 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |